Meeder Asset Management Inc Synlogic, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$1.59 - $2.51 $1,143 - $1,804	-719 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.39 - $3.19 $999 - $2,293	719 New	719 $1,000
Q4 2019 Feb 13, 2020	SELL	$1.96 - $2.81 $6,711 - $9,621	-3,424 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$2.12 - $9.37 $6,633 - $29,318	3,129 Added 1060.68%	3,424 $7,000
Q2 2019 Aug 05, 2019	BUY	$6.27 - $9.48 $884 - $1,336	141 Added 91.56%	295 $3,000
Q1 2019 Apr 16, 2019	SELL	$7.01 - $10.24 $1,037 - $1,515	-148 Reduced 49.01%	154 $1,000
Q4 2018 Jan 17, 2019	SELL	$5.95 - $14.49 $8,472 - $20,633	-1,424 Reduced 82.5%	302 $2,000
Q3 2018 Nov 02, 2018	BUY	$7.51 - $14.21 $7,945 - $15,034	1,058 Added 158.38%	1,726 $0
Q2 2018 Jul 24, 2018	BUY	$9.01 - $13.33 $6,018 - $8,904	668 New	668 $0

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $96.9M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.